Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Underexpression of RhoH in Hairy Cell Leukemia.

Galiègue-Zouitina S, Delestré L, Dupont C, Troussard X, Shelley CS.

Cancer Res. 2008 Jun 15;68(12):4531-40. doi: 10.1158/0008-5472.CAN-07-5661.

2.

CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy.

Poret N, Fu Q, Guihard S, Cheok M, Miller K, Zeng G, Quesnel B, Troussard X, Galiègue-Zouitina S, Shelley CS.

Cancer Res. 2015 Sep 15;75(18):3902-11. doi: 10.1158/0008-5472.CAN-15-0893. Erratum in: Cancer Res. 2015 Dec 1;75(23):5167.

3.

Repression of the RHOH gene by JunD.

Delestré L, Berthon C, Quesnel B, Figeac M, Kerckaert JP, Galiègue-Zouitina S, Shelley CS.

Biochem J. 2011 Jul 1;437(1):75-88. doi: 10.1042/BJ20100829.

PMID:
21473742
4.

RhoH is important for positive thymocyte selection and T-cell receptor signaling.

Dorn T, Kuhn U, Bungartz G, Stiller S, Bauer M, Ellwart J, Peters T, Scharffetter-Kochanek K, Semmrich M, Laschinger M, Holzmann B, Klinkert WE, Straten PT, Køllgaard T, Sixt M, Brakebusch C.

Blood. 2007 Mar 15;109(6):2346-55. Epub 2006 Nov 21.

5.

The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.

Del Giudice I, Matutes E, Morilla R, Morilla A, Owusu-Ankomah K, Rafiq F, A'Hern R, Delgado J, Bazerbashi MB, Catovsky D.

Haematologica. 2004 Mar;89(3):303-8.

6.

Hairy cell leukemia-variant--a case report.

Gupta K, Jasmina A, Malhotra P, Varma N, Vaiphei K, Vohra H, Varma S, Garewal G.

Indian J Pathol Microbiol. 2005 Jul;48(3):387-9.

PMID:
16761764
7.

Rearrangement of the RHOH gene in a case of splenic lymphoma with villous lymphocytes.

Bernicot I, Morel F, Le Bris MJ, Bail JP, Douet-Guilbert N, De Braekeleer M.

Cancer Genet Cytogenet. 2006 Oct 1;170(1):78-9. No abstract available.

PMID:
16965962
8.

Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.

Hockley SL, Morilla A, Else M, Dearden C, Catovsky D, Morgan GJ, Matutes E, Gonzalez D.

Leukemia. 2010 May;24(5):1084-6. doi: 10.1038/leu.2010.44. Epub 2010 Mar 18. No abstract available.

PMID:
20237507
9.

Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies.

Forconi F, Raspadori D, Lenoci M, Lauria F.

Haematologica. 2005 Feb;90(2):266-8.

10.

RhoH is required to maintain the integrin LFA-1 in a nonadhesive state on lymphocytes.

Cherry LK, Li X, Schwab P, Lim B, Klickstein LB.

Nat Immunol. 2004 Sep;5(9):961-7. Epub 2004 Aug 8.

PMID:
15300248
11.

RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans.

Troeger A, Johnson AJ, Wood J, Blum WG, Andritsos LA, Byrd JC, Williams DA.

Blood. 2012 May 17;119(20):4708-18. doi: 10.1182/blood-2011-12-395939. Epub 2012 Apr 3.

12.

Comparative expressed sequence hybridization studies of hairy cell leukemia show uniform expression profile and imprint of spleen signature.

Vanhentenrijk V, De Wolf-Peeters C, Wlodarska I; Belgian Programme of Interuniversity Poles of Attraction.

Blood. 2004 Jul 1;104(1):250-5. Epub 2004 Mar 11.

13.

Aberrant expression and localization of the cytoskeleton-binding pp52 (LSP1) protein in hairy cell leukemia.

Miyoshi EK, Stewart PL, Kincade PW, Lee MB, Thompson AA, Wall R.

Leuk Res. 2001 Jan;25(1):57-67.

PMID:
11137562
14.

Dissection of tumour and host cells from target organs of metastasis for testing gene expression directly ex vivo.

Rocha M, Hexel K, Bucur M, Schirrmacher V, Umansky V.

Br J Cancer. 1996 Oct;74(8):1216-22.

15.

RhoH/TTF negatively regulates leukotriene production in neutrophils.

Daryadel A, Yousefi S, Troi D, Schmid I, Schmidt-Mende J, Mordasini C, Dahinden CA, Ziemiecki A, Simon HU.

J Immunol. 2009 May 15;182(10):6527-32. doi: 10.4049/jimmunol.0803846.

16.

Prognostic implication and biological roles of RhoH in acute myeloid leukaemia.

Iwasaki T, Katsumi A, Kiyoi H, Tanizaki R, Ishikawa Y, Ozeki K, Kobayashi M, Abe A, Matsushita T, Watanabe T, Amano M, Kojima T, Kaibuchi K, Naoe T.

Eur J Haematol. 2008 Dec;81(6):454-60. doi: 10.1111/j.1600-0609.2008.01132.x. Epub 2008 Aug 6.

PMID:
18691253
17.

BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia.

Raess PW, Mintzer D, Husson M, Nakashima MO, Morrissette JJ, Daber R, Bagg A.

Blood. 2013 Oct 24;122(17):3084-5. doi: 10.1182/blood-2013-07-513523. No abstract available.

18.

RhoH GTPase: a key regulator of hematopoietic cell proliferation and apoptosis?

Gu Y, Zheng Y, Williams DA.

Cell Cycle. 2005 Feb;4(2):201-2. Epub 2005 Feb 18.

PMID:
15611634
19.

Initial molecular characterization of a novel Rho-type GTPase RhoH in the filamentous ascomycete Ashbya gossypii.

Walther A, Wendland J.

Curr Genet. 2005 Oct;48(4):247-55. Epub 2005 Nov 4.

PMID:
16160833
20.

[Lymphomas of the spleen].

Marx A, Müller-Hermelink HK, Hartmann M, Geissinger E, Zettl A, Adam P, Rüdiger T.

Pathologe. 2008 Mar;29(2):136-42. doi: 10.1007/s00292-008-0976-4. German.

PMID:
18214484

Supplemental Content

Support Center